OTU Domain: Characterizing and Potential Drug Targets (G55593)

Target Name: OTUD5

NCBI ID: G55593

OTUD5

OTU Domain: Characterizing and Potential Drug Targets

OTUD5, also known asOTU domain-containing protein 5 (isoform a), is a protein that is expressed in various tissues and organs throughout the body.OTU domain is a type of transmembrane domain that is found in many proteins, which are responsible for protein-protein interactions and for regulating various cellular processes.OTU domain is also known as tryptophan/tyrosine domain.

OTU domain is a protein that is characterized by the presence of a specific domain that is composed of three amino acids, known as tryptophan, tyr, and valine. This domain is responsible for the unique structure and function of the protein.OTU domain is also known as tryptophan/tyrosine domain because it contains the amino acids tryptophan and tyr, which are involved in the production of various neurotransmitters, such as serotonin and dopamine.

OTU domain is found in many different proteins, including neural and endocrine tissues, and is involved in various cellular processes. For example, OTU domain is involved in the regulation of neurotransmitter synthesis and release, as well as in the development and maintenance of neural circuits. It is also involved in the regulation of cell signaling pathways, including the TGF-β pathway.

In addition to its role in cellular signaling, OTU domain is also a potential drug target and biomarker.OTU domain is known to be involved in various signaling pathways, and therefore, it is a potential target for small molecules that can modulate these signaling pathways.OTU domain is also known as OTUD5 because it is the fifth protein to be shown to contain the tryptophan/tyrosine domain.

OTU domain has been shown to be involved in various signaling pathways, including the TGF-β pathway, the G protein-coupled receptor (GPCR) signaling pathway, and the neurotrophin signaling pathway. OTU domain has also been shown to play a role in the regulation of neurotransmitter synthesis and release, as well as in the development and maintenance of neural circuits.

OTU domain has also been shown to be involved in the regulation of cell signaling pathways, including the TGF-β pathway. TGF-β is a transcription factor that is involved in the regulation of cellular processes such as cell growth, differentiation, and inflammation. OTU domain has been shown to be involved in the regulation of TGF-β activity, which may have implications for the development of TGF-β-related diseases.

OTU domain has also been shown to be involved in the regulation of neurotransmitter synthesis and release, as well as in the development and maintenance of neural circuits. It is also involved in the regulation of cell signaling pathways, including the TGF-β pathway. OTU domain has been shown to play a role in the regulation of neurotransmitter synthesis and release by affecting the activity of various enzymes involved in this process, such as the neurotransmitter transporter SNAP25 and the neurotransmitter uptake system.

In addition to its role in neurotransmitter synthesis and release, OTU domain is also involved in the regulation of cell signaling pathways, including the TGF-β pathway. TGF-β is a transcription factor that is involved in the regulation of cellular processes such as cell growth, differentiation, and inflammation. OTU domain has been shown to be involved in the regulation of TGF-β activity, which may have implications for the development of TGF-β-related diseases.

OTU domain has also been shown to be involved in the regulation of neurotransmitter synthesis and release by affecting the activity of various enzymes involved in this process, such as the neurotransmitter transporter SNAP25 and the neurotransmitter uptake system. It is also involved in

Protein Name: OTU Deubiquitinase 5

Functions: Deubiquitinating enzyme that functions as negative regulator of the innate immune system. Acts via TRAF3 deubiquitination and subsequent suppression of type I interferon (IFN) production. Has peptidase activity towards 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains. Can also cleave 'Lys-11'-linked ubiquitin chains (in vitro). Controls neuroectodermal differentiation through cleaving 'Lys-48'-linked ubiquitin chains to counteract degradation of select chromatin regulators such as ARID1A, HDAC2 and HCF1 (PubMed:33523931)

The "OTUD5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OTUD5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets